Washington U to get $10 million for rare disease research
Washington University School of Medicine is partnering with Mallinckrodt Pharmaceuticals on a new research partnership to pursue new therapies for patients with complex conditions.
Mallinckrodt will fund up to $10 million in grants over five years to support the research projects. The grants will be awarded on a competitive basis, with projects selected by a committee of experts from the university and the company.
“Washington University is a research powerhouse, and by p artnering with Mallinckrodt…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Veneta Rizvic Source Type: news
More News: Grants | Health Management | Partnerships | Pharmaceuticals | Rare Diseases | Washington University